Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Thorax 2007;62:195-196; doi:10.1136/thx.2006.070623
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Town, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Town, I.
Topic Collections
Right arrowRelevant Articles

EDITORIAL

RCTs and asthma

Applying the results of randomised control trials on asthma

Ian Town

Correspondence to:
Correspondence to:
Professor I Town
University of Canterbury, PB 4800, Christchurch 8001, New Zealand; ian.town@canterbury.ac.nz


Guidelines for management of common medical conditions are just guidelines—to be used and interpreted by health practitioners

The first 150 words of the full text of this article appear below.

An important article by Peter Rothwell1 published in the Lancet in 2005 eloquently summarised issues concerning the external validity of randomised controlled trials (RCTs). The issue underlying the question "to whom do the results of this trial apply?" is sometimes referred to as generalisability and reporting on this is now a standard requirement for articles published by many journals directed at a general audience.

Rothwell summarises several factors that must be taken into account when considering generalisability, including the trial setting, patient selection, the characteristics of the patients randomised, the type of outcome measures employed, the nature and duration of follow-up, and the completeness of adverse event reporting. Further, differences between the trial protocol and routine local practice must be taken into account, especially the possibility, given the likely time elapsed between the trial design and reporting, that considerable therapeutic or diagnostic advances have occurred in the . . . [Full text of this article]


Relevant Articles

Airwaves
Wisia Wedzicha
Thorax 2007 62: 193. [Extract] [Full Text] [PDF]

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?
Justin Travers, Suzanne Marsh, Mathew Williams, Mark Weatherall, Brent Caldwell, Philippa Shirtcliffe, Sarah Aldington, and Richard Beasley
Thorax 2007 62: 219-223. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society